TET2 and myeloid neoplasm: Finally, single-cell analysis of myeloid malignancies performed by Miles and colleagues15 revealed the co-occurrence of IDH1/2 and TET2 mutations, which had never been reported before in myeloid neoplasms, as the two mutations were previously described to be mutually exclusive23.